0000000000650698

AUTHOR

Remedios Otero-candelera

0000-0002-2265-1221

showing 2 related works from this author

Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group)

2020

Background The aim was to analyze the temporal relationship between short-term air pollution exposure and acute symptomatic unprovoked pulmonary embolism (PE). Patients/methods We performed a prospective, multicenter study in consecutive patients diagnosed with acute symptomatic unprovoked PE from February 2012 to January 2013. We analyzed demographic and clinical data, patients' addresses, meteorological and air pollutants data (PM10, SO2, CO, NO2, ozone emission data). We considered the number of days the patient had symptoms, and the study period constituted the previous 30 days. Likewise, the mean annual data of the reference season were calculated as well as the data of the 30-day stud…

medicine.medical_specialtyLung embolismAir pollution exposureAir pollution030204 cardiovascular system & hematologyCorrelation03 medical and health sciences0302 clinical medicineAir pollutantsInternal medicineAir PollutionmedicineHumansProspective StudiesLungNitrogen dioxideAir Pollutantsbusiness.industryPulmonary embolismHematologyEnvironmental Exposuremedicine.diseasePulmonary embolismMulticenter study030220 oncology & carcinogenesisPyrazinesObservational studyParticulate MatterbusinessPulmonary EmbolismParticulate matterAir pollutants
researchProduct

Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight hep…

2019

Background: The aim of our study was to investigate whether anti-Xa levels assessed in selected groups of LMWH-treated patients with VTE correlate with the risk of developing thromboembolic or bleeding complications. Methods: Retrospective study, in adult patients treated with anti-Xa-adjusted LMWH analysing the association between anti-Xa activity and recurrent VTE or bleeding. Primary outcomes were symptomatic fatal or nonfatal objectively diagnosed VTE and clinically relevant bleeding (ISTH criteria). Results: From 2007-2017, 192 patients were recruited. Mean age was 62 (SD 18) years and 48% were men. Indications for anti-Xa monitoring were: VTE recurrence under anticoagulation (20.8%), …

medicine.medical_specialtyAdult patientsmedicine.drug_classbusiness.industryLow molecular weight heparinMean ageRetrospective cohort studyInternal medicineRelative riskmedicineIn patientcardiovascular diseasesAnti factor xabusinessVenous thromboembolismPulmonary embolism
researchProduct